Local Glioma Cells Are Associated with Vascular Dysregulation

References

1. 1.↵
   2. Watkins S,
   3. Robel S,
   4. Kimbrough IF, et al

   . Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 2014;5:4196 doi:10.1038/ncomms5196 pmid:24943270

   CrossRefPubMed
2. 2.↵
   2. Persidsky Y,
   3. Ramirez SH,
   4. Haorah J, et al

   . Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006;1:223–36 doi:10.1007/s11481-006-9025-3 pmid:18040800

   CrossRefPubMed
3. 3.↵
   2. Cuddapah VA,
   3. Robel S,
   4. Watkins S, et al

   . A neurocentric perspective on glioma invasion. Nat Rev Neurosci 2014;15:455–65 doi:10.1038/nrn3765 pmid:24946761

   CrossRefPubMed
4. 4.↵
   2. Wen PY,
   3. Macdonald DR,
   4. Reardon DA, et al

   . Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group. J Clin Oncol 2010;28:1963–72 doi:10.1200/JCO.2009.26.3541 pmid:20231676

   Abstract/FREE Full Text
5. 5.↵
   2. Pillai JJ,
   3. Zacà D

   . Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors. Technol Cancer Res Treat 2012;11:361–74 doi:10.7785/tcrt.2012.500284 pmid:22376130

   CrossRefPubMed
6. 6.↵
   2. Hsu YY,
   3. Chang CN,
   4. Jung SM, et al

   . Blood oxygenation level-dependent MRI of cerebral gliomas during breath holding. J Magn Reson Imaging 2004;19:160–67 doi:10.1002/jmri.10447 pmid:14745748

   CrossRefPubMed
7. 7.↵
   2. Zacà D,
   3. Jovicich J,
   4. Nadar SR, et al

   . Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI. J Magn Reson Imaging 2014;40:383–90 doi:10.1002/jmri.24406 pmid:24338845

   CrossRefPubMed
8. 8.↵
   2. Holodny AI,
   3. Schulder M,
   4. Liu WC, et al

   . The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. AJNR Am J Neuroradiol 2000;21:1415–22 pmid:11003273

   Abstract/FREE Full Text
9. 9.↵
   2. Hou BL,
   3. Bradbury M,
   4. Peck KK, et al

   . Effect of brain tumor neovasculature defined by rCBV on BOLD fMRI activation volume in the primary motor cortex. Neuroimage 2006;32:489–97 doi:10.1016/j.neuroimage.2006.04.188 pmid:16806983

   CrossRefPubMed
10. 10.↵
    2. Jiang Z,
    3. Krainik A,
    4. David O, et al

    . Impaired fMRI activation in patients with primary brain tumors. Neuroimage 2010;52:538–48 doi:10.1016/j.neuroimage.2010.04.194 pmid:20452442

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Schreiber A,
    3. Hubbe U,
    4. Ziyeh S, et al

    . The influence of gliomas and nonglial space-occupying lesions on blood-oxygen-level-dependent contrast enhancement. AJNR Am J Neuroradiol 2000;21:1055–63 pmid:10871013

    Abstract/FREE Full Text
12. 12.↵
    2. Chow DS,
    3. Horenstein CI,
    4. Canoll P, et al

    . Glioblastoma induces vascular dysregulation in nonenhancing peritumoral regions in humans. AJR Am J Roentgenol 2016;206:1073–81 doi:10.2214/AJR.15.14529 pmid:27007449

    CrossRefPubMed
13. 13.↵
    2. Shmueli K,
    3. van Gelderen P,
    4. de Zwart JA, et al

    . Low-frequency fluctuations in the cardiac rate as a source of variance in the resting-state fMRI BOLD signal. Neuroimage 2007;38:306–20 doi:10.1016/j.neuroimage.2007.07.037 pmid:17869543

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Murphy K,
    3. Birn RM,
    4. Handwerker DA, et al

    . The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? Neuroimage 2009;44:893–905 doi:10.1016/j.neuroimage.2008.09.036 pmid:18976716

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Birn RM,
    3. Murphy K,
    4. Bandettini PA

    . The effect of respiration variations on independent component analysis results of resting state functional connectivity. Hum Brain Mapp 2008;29:740–50 doi:10.1002/hbm.20577 pmid:18438886

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Liu P,
    3. Li Y,
    4. Pinho M, et al

    . Cerebrovascular reactivity mapping without gas challenges. Neuroimage 2017;146:320–26 doi:10.1016/j.neuroimage.2016.11.054 pmid:27888058

    CrossRefPubMed
17. 17.↵
    2. Holodny AI,
    3. Schulder M,
    4. Liu WC, et al

    . Decreased BOLD functional MR activation of the motor and sensory cortices adjacent to a glioblastoma multiforme: implications for image-guided neurosurgery. AJNR Am J Neuroradiol 1999;20:609–12 pmid:10319970

    Abstract/FREE Full Text
18. 18.↵
    2. Chang PD,
    3. Malone HR,
    4. Bowden S, et al

    . A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 2017;38:890–98 doi:10.3174/ajnr.A5112 pmid:28255030

    Abstract/FREE Full Text
19. 19.↵
    2. Jenkinson M,
    3. Beckmann CF,
    4. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Beckmann CF,
    3. Smith SM

    . Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 2004;23:137–52 doi:10.1109/TMI.2003.822821 pmid:14964560

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Calli C,
    3. Kitis O,
    4. Yunten N, et al

    . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403 doi:10.1016/j.ejrad.2005.12.032 pmid:16527438

    CrossRefPubMed
22. 22.↵
    2. Hakyemez B,
    3. Erdogan C,
    4. Bolca N, et al

    . Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24:817–24 doi:10.1002/jmri.20707 pmid:16958061

    CrossRefPubMed
23. 23.↵
    2. Tyler JL,
    3. Diksic M,
    4. Villemure JG, et al

    . Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987;28:1123–33 pmid:3496433

    Abstract/FREE Full Text
24. 24.↵
    2. Schramm P,
    3. Xyda A,
    4. Klotz E, et al

    . Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010;20:2482–90 doi:10.1007/s00330-010-1817-4 pmid:20495977

    CrossRefPubMed
25. 25.↵
    2. Noguchi T,
    3. Yoshiura T,
    4. Hiwatashi A, et al

    . Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 2008;29:688–93 doi:10.3174/ajnr.A0903 pmid:18184842

    Abstract/FREE Full Text
26. 26.↵
    2. Tourdias T,
    3. Rodrigo S,
    4. Oppenheim C, et al

    . Pulsed arterial spin labeling applications in brain tumors: practical review. J Neuroradiol 2008;35:79–89 doi:10.1016/j.neurad.2007.11.007 pmid:18206239

    CrossRefPubMed
27. 27.↵
    2. Cha S,
    3. Yang L,
    4. Johnson G, et al

    . Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 2006;27:409–17 pmid:16484420

    Abstract/FREE Full Text
28. 28.↵
    2. Kelly PJ

    . Computed tomography and histologic limits in glial neoplasms: tumor types and selection for volumetric resection. Surg Neurol 1993;39:458–65 doi:10.1016/0090-3019(93)90031-U pmid:8390726

    CrossRefPubMed
29. 29.↵
    2. Earnest F 4th.,
    3. Kelly PJ,
    4. Scheithauer BW, et al

    . Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988;166:823–27 doi:10.1148/radiology.166.3.2829270 pmid:2829270

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Greene GM,
    3. Hitchon PW,
    4. Schelper RL, et al

    . Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 1989;71:494–97 doi:10.3171/jns.1989.71.4.0494 pmid:2677263

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Nagashima G,
    3. Suzuki R,
    4. Hokaku H, et al

    . Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma. Surg Neurol 1999;51:292–99 doi:10.1016/S0090-3019(98)00056-1 pmid:10086494

    CrossRefPubMed
32. 32.↵
    2. Pronin IN,
    3. Holodny AI,
    4. Petraikin AV

    . MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradiology 1997;39:348–50 doi:10.1007/s002340050421 pmid:9189880

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Pronin IN,
    3. McManus KA,
    4. Holodny AI, et al

    . Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors. J Neurooncol 2009;94:399–408 doi:10.1007/s11060-009-9872-x pmid:19330483

    CrossRefPubMed
34. 34.↵
    2. Iranmahboob A,
    3. Peck KK,
    4. Brennan NP, et al

    . Vascular reactivity maps in patients with gliomas using breath-holding BOLD fMRI. J Neuroimaging 2016;26:232–39 doi:10.1111/jon.12278 pmid:26250554

    CrossRefPubMed
35. 35.↵
    2. Agarwal S,
    3. Sair HI,
    4. Pillai JJ

    . The resting-state functional magnetic resonance imaging regional homogeneity metrics, Kendall's coefficient of concordance, regional homogeneity and coherence, regional homogeneity are valid indicators of tumor-related neurovascular uncoupling. Brain Connect 2017;7:228–35 doi:10.1089/brain.2016.0482 pmid:28363248

    CrossRefPubMed
36. 36.↵
    2. Agarwal S,
    3. Lu H,
    4. Pillai JJ

    . Value of frequency domain resting-state functional magnetic resonance imaging metrics amplitude of low-frequency fluctuation and fractional amplitude of low-frequency fluctuation in the assessment of brain tumor-induced neurovascular uncoupling. Brain Connect 2017;7:382–89 doi:10.1089/brain.2016.0480 pmid:28657344

    CrossRefPubMed
37. 37.↵
    2. Choi SH,
    3. Kim JW,
    4. Chang JS, et al

    . Impact of including peritumoral edema in radiotherapy target volume on patterns of failure in glioblastoma following temozolomide-based chemoradiotherapy. Sci Rep 2017;7:42148 doi:10.1038/srep42148 pmid:28176884

    CrossRefPubMed
38. 38.↵
    2. Bartolomei F,
    3. Bosma I,
    4. Klein M, et al

    . How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol 2006;59:128–38 doi:10.1002/ana.20710 pmid:16278872

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Maesawa S,
    3. Bagarinao E,
    4. Fujii M, et al

    . Evaluation of resting state networks in patients with gliomas: connectivity changes in the unaffected side and its relation to cognitive function. PLoS One 2015;10:e0118072 doi:10.1371/journal.pone.0118072 pmid:25659130

    CrossRefPubMed
40. 40.↵
    2. Esposito R,
    3. Mattei PA,
    4. Briganti C, et al

    . Modifications of default-mode network connectivity in patients with cerebral glioma. PLoS One 2012;7:e40231 doi:10.1371/journal.pone.0040231 pmid:22808124

    CrossRefPubMed
41. 41.↵
    2. Harris RJ,
    3. Bookheimer SY,
    4. Cloughesy TF, et al

    . Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neurooncol 2014;116:373–79 doi:10.1007/s11060-013-1304-2 pmid:24234804

    CrossRefPubMed
42. 42.↵
    2. Park JE,
    3. Kim HS,
    4. Kim SJ, et al

    . Alteration of long-distance functional connectivity and network topology in patients with supratentorial gliomas. Neuroradiology 2016;58:311–20 doi:10.1007/s00234-015-1621-6 pmid:26635295

    CrossRefPubMed
43. 43.↵
    2. Hillman EM

    . Coupling mechanism and significance of the BOLD signal: a status report. Annu Rev Neurosci 2014;37:161–81 doi:10.1146/annurev-neuro-071013-014111 pmid:25032494

    CrossRefPubMed
44. 44.↵
    2. Araque A,
    3. Parpura V,
    4. Sanzgiri RP, et al

    . Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999;22:208–15 doi:10.1016/S0166-2236(98)01349-6 pmid:10322493

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Hervey-Jumper SL,
    3. Berger MS

    . Maximizing safe resection of low- and high-grade glioma. J Neurooncol 2016;130:269–82 doi:10.1007/s11060-016-2110-4 pmid:27174197

    CrossRefPubMed
46. 46.↵
    2. Duffau H

    . Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up. Acta Neurochir (Wien) 2016;158:51–58 doi:10.1007/s00701-015-2621-3 pmid:26530708

    CrossRefPubMed